Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.addr.2010.02.005
Title: Cell-delivery therapeutics for liver regeneration
Authors: Zhang, W. 
Chang, S.
Jia, R. 
Shen, S. 
Yu, H. 
Tucker-Kellogg, L. 
Venkatraman, L. 
Lu, Y.
White, J.K.
Bhowmick, S.S.
Dewey, C.F.
Narmada, B.C.
Tan, N.
Keywords: Cell transplantation
Delivery vehicles
Encapsulation
Hepatocytes
Liver regeneration
Scaffolds
Stem cells
Systems Biology
Xenogenic cells
Issue Date: 2010
Source: Zhang, W., Chang, S., Jia, R., Shen, S., Yu, H., Tucker-Kellogg, L., Venkatraman, L., Lu, Y., White, J.K., Bhowmick, S.S., Dewey, C.F., Narmada, B.C., Tan, N. (2010). Cell-delivery therapeutics for liver regeneration. Advanced Drug Delivery Reviews 62 (7-8) : 814-826. ScholarBank@NUS Repository. https://doi.org/10.1016/j.addr.2010.02.005
Abstract: For acute, chronic, or hereditary diseases of the liver, cell transplantation therapies can stimulate liver regeneration or serve as a bridge until liver transplantation can be performed. Recently, fetal hepatocytes, stem cells, liver progenitor cells, or other primitive and proliferative cell types have been employed for cell transplantation therapies, in an effort to improve the survival, proliferation, and engraftment of the transplanted cells. Reviewing earlier studies, which achieved success by transplanting mature hepatocytes, we propose that there is a switch-like regulation of liver regeneration that changes state according to a stimulus threshold of extracellular influences such as cytokines, matrices and neighboring cells. Important determinants of a successful clinical outcome include sufficient quantities and functional levels of the transplanted cells (even for short periods to alter the environment), rather than just engraftment levels or survival durations of the exogenously transplanted cells. The relative importance of these determining factors will impact future choices of cell sources, delivery vehicles, and sites of cell transplantation to stimulate liver regeneration for patients with severe liver diseases. © 2010 Elsevier B.V.
Source Title: Advanced Drug Delivery Reviews
URI: http://scholarbank.nus.edu.sg/handle/10635/25194
ISSN: 0169409X
DOI: 10.1016/j.addr.2010.02.005
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

23
checked on Dec 6, 2017

WEB OF SCIENCETM
Citations

16
checked on Nov 17, 2017

Page view(s)

248
checked on Dec 10, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.